ENTITY
Voronoi

Voronoi (310210 KS)

14
Analysis
Health Care • South Korea
Voronoi, Inc. operates as a drugs development company. The Company develops and manufactures kinase inhibitor and other new drugs. Voronoi provides services in Korea.
more
bearish•Bionote
•31 May 2023 17:02

End of Mandatory Lock-Up Periods for 45 Companies in Korea in June 2023

We discuss the end of the mandatory lock-up periods for 45 stocks in Korea in June 2023, among which 6 are in KOSPI and 39 are in KOSDAQ.

Logo
510 Views
Share
•01 Jul 2022 02:31

End of Mandatory Lock-Up Periods for 40 Companies in Korea in July 2022

We discuss end of the mandatory lock-up periods for 40 stocks in Korea in July 2022.Among these 40 stocks, LG Energy Solution could face further...

Logo
675 Views
Share
bearish•Voronoi
•14 May 2022 01:39

Voronoi: Reduces IPO Price Range by 25%

Voronoi is trying again to complete its IPO in Korea after lowering its IPO price range by 25% to 40,000 won to 46,000 won.

Logo
627 Views
Share
bullish•Voronoi
•25 Jan 2022 00:51

Voronoi IPO Preview

Voronoi has developed a genotype-directed therapy that is effective for tumors caused by mutations in kinases, and has successfully conducted...

Logo
361 Views
Share
x